The present authors conducted an open-label pilot examine that administered psilocybin to fifteen procedure-resistant tobacco/nicotine-dependent smokers, in the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Contributors ended up administered ~0.29 mg/kg oral psilocybin to the participant’s focus on date to qui